Cargando…

Type 1 diabetes defined by severe insulin deficiency occurs after 30 years of age and is commonly treated as type 2 diabetes

AIMS/HYPOTHESIS: Late-onset type 1 diabetes can be difficult to identify. Measurement of endogenous insulin secretion using C-peptide provides a gold standard classification of diabetes type in longstanding diabetes that closely relates to treatment requirements. We aimed to determine the prevalence...

Descripción completa

Detalles Bibliográficos
Autores principales:	Thomas, Nicholas J., Lynam, Anita L., Hill, Anita V., Weedon, Michael N., Shields, Beverley M., Oram, Richard A., McDonald, Timothy J., Hattersley, Andrew T., Jones, Angus G.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Berlin Heidelberg 2019
Materias:	Short Communication
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6559997/ https://www.ncbi.nlm.nih.gov/pubmed/30969375 http://dx.doi.org/10.1007/s00125-019-4863-8

Ejemplares similares

Development and validation of multivariable clinical diagnostic models to identify type 1 diabetes requiring rapid insulin therapy in adults aged 18–50 years
por: Lynam, Anita, et al.
Publicado: (2019)

The majority of patients with long-duration type 1 diabetes are insulin microsecretors and have functioning beta cells
por: Oram, Richard A., et al.
Publicado: (2013)

Logistic regression has similar performance to optimised machine learning algorithms in a clinical setting: application to the discrimination between type 1 and type 2 diabetes in young adults
por: Lynam, Anita L., et al.
Publicado: (2020)

Erratum to: The majority of patients with long-duration type 1 diabetes are insulin microsecretors and have functioning beta cells
por: Oram, Richard A., et al.
Publicado: (2013)

Identifying clinical criteria to predict Type 1 diabetes, as defined by absolute insulin deficiency: a systematic review protocol
por: Shields, Beverley M, et al.
Publicado: (2012)

Frequency and phenotype of type 1 diabetes in the first six decades of life: a cross-sectional, genetically stratified survival analysis from UK Biobank
por: Thomas, Nicholas J, et al.
Publicado: (2018)

Studies of insulin and proinsulin in pancreas and serum support the existence of aetiopathological endotypes of type 1 diabetes associated with age at diagnosis
por: Leete, Pia, et al.
Publicado: (2020)

Choice of HbA1c threshold for identifying individuals at high risk of type 2 diabetes and implications for diabetes prevention programmes: a cohort study
por: Rodgers, Lauren R., et al.
Publicado: (2021)

Random non-fasting C-peptide testing can identify patients with insulin-treated type 2 diabetes at high risk of hypoglycaemia
por: Hope, Suzy V., et al.
Publicado: (2017)

Combining Information from Common Type 2 Diabetes Risk Polymorphisms Improves Disease Prediction
por: Weedon, Michael N, et al.
Publicado: (2006)

Assessment of endogenous insulin secretion in insulin treated diabetes predicts postprandial glucose and treatment response to prandial insulin
por: Jones, Angus G, et al.
Publicado: (2012)

Cohort profile for the MASTERMIND study: using the Clinical Practice Research Datalink (CPRD) to investigate stratification of response to treatment in patients with type 2 diabetes
por: Rodgers, Lauren R, et al.
Publicado: (2017)

Lower Circulating B12 Is Associated with Higher Obesity and Insulin Resistance during Pregnancy in a Non-Diabetic White British Population
por: Knight, Bridget Ann, et al.
Publicado: (2015)

Identifying Good Responders to Glucose Lowering Therapy in Type 2 Diabetes: Implications for Stratified Medicine
por: Jones, Angus G., et al.
Publicado: (2014)

Urine C-peptide creatinine ratio can be used to assess insulin resistance and insulin production in people without diabetes: an observational study
por: Oram, Richard A, et al.
Publicado: (2013)

Urinary C‐peptide creatinine ratio detects absolute insulin deficiency in Type 2 diabetes
por: Hope, S. V., et al.
Publicado: (2013)

Practical Classification Guidelines for Diabetes in patients treated with insulin: a cross-sectional study of the accuracy of diabetes diagnosis
por: Hope, Suzy V, et al.
Publicado: (2016)

The functional "KL-VS" variant of KLOTHO is not associated with type 2 diabetes in 5028 UK Caucasians
por: Freathy, Rachel M, et al.
Publicado: (2006)

Urine C-Peptide Creatinine Ratio Is a Noninvasive Alternative to the Mixed-Meal Tolerance Test in Children and Adults With Type 1 Diabetes
por: Besser, Rachel E.J., et al.
Publicado: (2011)

Evaluating associations between the benefits and risks of drug therapy in type 2 diabetes: a joint modeling approach
por: Dennis, John M, et al.
Publicado: (2018)

Polygenic Risk Variants for Type 2 Diabetes Susceptibility Modify Age at Diagnosis in Monogenic HNF1A Diabetes
por: Lango Allen, Hana, et al.
Publicado: (2010)

A study of association between common variation in the growth hormone-chorionic somatomammotropin hormone gene cluster and adult fasting insulin in a UK Caucasian population
por: Freathy, Rachel M, et al.
Publicado: (2006)

Can clinical features be used to differentiate type 1 from type 2 diabetes? A systematic review of the literature
por: Shields, Beverley M, et al.
Publicado: (2015)

Disease progression and treatment response in data-driven subgroups of type 2 diabetes compared with models based on simple clinical features: an analysis using clinical trial data
por: Dennis, John M, et al.
Publicado: (2019)

Comparison of causal forest and regression-based approaches to evaluate treatment effect heterogeneity: an application for type 2 diabetes precision medicine
por: Venkatasubramaniam, Ashwini, et al.
Publicado: (2023)

Identifying routine clinical predictors of non‐adherence to second‐line therapies in type 2 diabetes: A retrospective cohort analysis in a large primary care database
por: Shields, Beverley M., et al.
Publicado: (2019)

Biphasic insulin aspart 30/70 (BIAsp 30) in the treatment of type 1 and type 2 diabetes
por: Valensi, Paul
Publicado: (2009)

Clinical prediction models combining routine clinical measures identify participants with youth-onset diabetes who maintain insulin secretion in the range associated with type 2 diabetes: The SEARCH for Diabetes in Youth Study
por: Jones, Angus G, et al.
Publicado: (2023)

Patient preference for second and third line therapies in type 2 diabetes: a prespecified secondary endpoint of the TriMaster study
por: Shields, Beverley M, et al.
Publicado: (2023)

Assessing the Combined Impact of 18 Common Genetic Variants of Modest Effect Sizes on Type 2 Diabetes Risk
por: Lango, Hana, et al.
Publicado: (2008)

Are we missing hypoglycaemia? Elderly patients with insulin-treated diabetes present to primary care frequently with non-specific symptoms associated with hypoglycaemia
por: Hope, Suzy V., et al.
Publicado: (2018)

Urinary C-Peptide Creatinine Ratio Is a Practical Outpatient Tool for Identifying Hepatocyte Nuclear Factor 1-α/Hepatocyte Nuclear Factor 4-α Maturity-Onset Diabetes of the Young From Long-Duration Type 1 Diabetes
por: Besser, Rachel E.J., et al.
Publicado: (2011)

The relationship between islet autoantibody status and the genetic risk of type 1 diabetes in adult-onset type 1 diabetes
por: Thomas, Nicholas J., et al.
Publicado: (2022)

Utility of genetic risk scores in type 1 diabetes
por: Luckett, Amber M., et al.
Publicado: (2023)

Should Studies of Diabetes Treatment Stratification Correct for Baseline HbA1c?
por: Jones, Angus G., et al.
Publicado: (2016)

Patient stratification for determining optimal second and third line therapy for type 2 diabetes: the TriMaster study
por: Shields, Beverley M, et al.
Publicado: (2023)

Skeletal Response to Insulin in the Naturally Occurring Type 1 Diabetes Mellitus Mouse Model
por: Dixit, Manisha, et al.
Publicado: (2021)

Hybrid Insulin Peptides Are Autoantigens in Type 1 Diabetes
por: Baker, Rocky L., et al.
Publicado: (2019)

Five-Year Follow-Up for Women With Subclinical Hypothyroidism in Pregnancy
por: Shields, Beverley M., et al.
Publicado: (2013)

15 Years of Experience with Biphasic Insulin Aspart 30 in Type 2 Diabetes
por: Liebl, Andreas, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_830j40vjpdcjjnnh9gpmmmhkeh